After Congress failed to pass a funding bill, the government shut down early Wednesday morning, which has significant implications for healthcare, including the future of telehealth flexibilities and ...

In the past couple of years, payers have come under scrutiny as they increasingly adopt AI tools to automate tasks like the claims review and prior authorization requests. Providers have voiced ...

More than 400 rural hospitals across the country are at risk of closure, battling a mix of reimbursement issues, workforce struggles and policy decisions that have left safety net providers ...

Much of President Donald Trump’s Tuesday State of the Union address centered on immigration and tariffs. However, he also addressed several healthcare issues, including a renewed criticism of the ...

Healthcare leaders must resist using AI as a substitute for staffing. Instead, invest in workforce optimization technology that empowers nurses, creates flexible pathways, and addresses the systemic ...

ICHRA — Individual Coverage Health Reimbursement Arrangement — seems to be the new buzzword of 2025. The interest in ICHRA stems from dissatisfaction with traditional group health insurance. The ...

Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment ...

When it comes to loyalty, many industries might immediately come to mind, but what about health care? Loyalty in health care has been talked about for some time, yet the reality is that the ...

A Hengrui Pharma obesity drug designed to hit two targets led to an average of nearly 18% weight loss in a pivotal study, paving the way for a regulatory submission in China, where the trial was ...

Giving healthcare teams powerful AI tools without training undermines their ability to use potentially system-changing tools ...

Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, ...

OpenEvidence’s $12 billion valuation reflects investor confidence in its bottom-up, doctor-first model. It has driven rapid adoption, with more than 757,000 clinicians using the startup’s free AI ...